Charles Moon, MD
Dermatology · Cape Girardeau, MONPI 1487712295
Payments from drug & device makers
Across 1,007 payments — averaging $293.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$143K
- Sun Pharmaceutical Industries Inc.$93K
- Lilly USA, LLC$49K
- Johnson & Johnson$1K
- Novartis$1K
- UCB, Inc.$1K
- plus $6K from 28 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 310 | $142,608 |
| Sun Pharmaceutical Industries Inc. | 92 | $93,494 |
| Lilly USA, LLC | 123 | $49,387 |
| Johnson & Johnson | 56 | $1,459 |
| Novartis | 77 | $1,402 |
| UCB, Inc. | 42 | $1,091 |
| Amgen | 40 | $985 |
| Regeneron Healthcare Solutions, Inc. | 29 | $768 |
| LEO Pharma Inc. | 28 | $667 |
| Galderma Laboratories, L.p. | 43 | $543 |
| Strata Skin Sciences, Inc. | 10 | $454 |
| Dermavant Sciences, Inc. | 30 | $452 |
| Sanofi | 18 | $378 |
| Bristol Myers Squibb | 8 | $292 |
| Pfizer | 17 | $278 |
| E.r. Squibb & Sons, L.L.C. | 22 | $259 |
| Convatec Inc. | 5 | $129 |
| Revance Therapeutics, Inc. | 2 | $112 |
| Incyte Corporation | 6 | $110 |
| Aclaris Therapeutics, Inc. | 5 | $101 |
| Arcutis Biotherapeutics, Inc. | 6 | $99 |
| Genentech USA, Inc. | 6 | $91 |
| Botanix SB Inc | 5 | $90 |
| Organon | 5 | $61 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 4 | $51 |
| Merck | 3 | $43 |
| Smith+Nephew | 3 | $41 |
| DUSA Pharmaceuticals, Inc. | 2 | $40 |
| Boehringer Ingelheim | 2 | $38 |
| Almirall LLC | 2 | $28 |
| Biofrontera Inc. | 2 | $23 |
| Dermira, Inc. | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Romark Laboratories, LC | 2 | $0 |
How this compares
$295,615 in reported general payments places this provider in the 95th percentile of 263 dermatology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other dermatology in Cape Girardeau
- Lawrence FeigenbaumCape Girardeau$37K
- Richard LimbertCape Girardeau$12K
- Melody StoneSaint Joseph$4.3M
- Milan AnadkatSaint Louis$2.4M
- Brian KimSaint Louis$2.3M
- Elaine SiegfriedSaint Louis$2.2M
- Craig LeonardiSaint Louis$1.7M
- David CleaverKirksville$789K
- Amy MusiekSaint Louis$577K
- Ann MartinSaint Louis$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.